The level of miR-23a is elevated in CAD patients and miR-23a regulates telomere shortening through telomeric repeat binding factor 2 (TRF2), suggesting that miR-23a might be able to modulate senescence [120]. Here, TERF2 is linked to coronary artery disorder.